Data regarding the usefulness of percutaneous coronary intervention (PCI) with drug eluting balloon (DEB) vs. thin struts drug eluting stents (thin-DES) for treating in-stent restenosis (ISR) in every day clinical practice is scarce. We aimed to evaluate comparing the efficacy and safety profile of DEB and thin-DES in DES-ISR.
Study Type
OBSERVATIONAL
Enrollment
1,369
Percutaneous coronary intervention with drug eluting balloon (DEB) vs. thin struts drug eluting stents (thin-DES) for treating in-stent restenosis (ISR)
Department of Invasive Cardiology, Medical University of Bialystok
Bialystok, Poland
Cardiovascular Institute, Nicolaus Copernicus University, Bydgoszcz, Poland
Bydgoszcz, Poland
First Department of Cardiology, Medical University of Gdansk, Gdansk, Poland
Gdansk, Poland
TLR
target lesion revascularisation
Time frame: 3 years
DOCE
composite of cardiac death, TLR, and target vessel MI
Time frame: 3 years
TVR
target vessel revascularization
Time frame: 3 years
TV-MI
target vessel myocardial infarction
Time frame: 3 years
cardiac death
Time frame: 3 years
myocardial infarction
Time frame: 3 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Department of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland
Katowice, Poland
Second Department of Cardiology, Jagiellonian University Medical College, Krakow, Poland
Krakow, Poland
Department of Interventional Cardiology and Angiology, National Institute of Cardiology, Warsaw, Poland
Warsaw, Poland
Department of Invasive Cardiology, Centre of Postgraduate Medical Education, Central Clinical Hospital of the Ministry of Interior and Administration
Warsaw, Poland
Centre for Heart Disease, University Hospital Wroclaw Department of Heart Disease, Wroclaw Medical University
Wroclaw, Poland
Third Department of Cardiology, Medical University of Katowice
Zabrze, Poland